Abstract
Cardiac complications following stroke or acute cerebrovascular accidents (CVA) are common; however, many of these complications are asymptomatic and do not cause adverse cardiac effects. Symptomatic events (such as acute myocardial infarction after CVA) rarely occur and are often the result of an underlying cardiac embolic source, such as a left ventricular thrombus. We report a case of spontaneous coronary thrombosis following thrombolytic therapy for acute CVA, and discuss the implication that an underlying systemic pro-thrombotic state may predispose individuals to thrombosis in disparate vascular beds.
Similar content being viewed by others
References
Chin PL, Kaminski J, Rout M (1977) Myocardial infarction coincident with cerebrovascular accidents in the elderly. Age Ageing 6:29–37
Johnston KC, Li JY, Lyden PD, Hanson SK, Feasby TE et al (1998) Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS investigators. Stroke 29:447–453
Chalela JA, Ezzeddine MA, Davis L, Warach S (2004) Myocardial injury in acute stroke: a troponin I study. Neurocrit Care 1:343–346
Sweta A, Sejal S, Prakash S, Vinay C, Shirish H (2010) Acute myocardial infarction following intravenous tissue plasminogen activator for acute ischemic stroke: an unknown danger. Ann Indian Acad Neurol 13:64–66
Mehdiratta M, Murphy C, Al-Harthi A, Teal PA (2007) Myocardial infarction following t-PA for acute stroke. Can J Neurol Sci 34:417–420
Meissner W, Lempert T, Saeuberlich-Knigge S, Bocksch W, Pape UF (2006) Fatal embolic myocardial infarction after systemic thrombolysis for stroke. Cerebrovasc Dis 22:213–214
Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L et al (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American heart association/American stroke association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: the American academy of neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115:e478–e534
Sen S, Laowatana S, Lima J, Oppenheimer SM (2004) Risk factors for intracardiac thrombus in patients with recent ischaemic cerebrovascular events. J Neurol Neurosurg Psychiatry 75:1421–1425
Garg A, Yaduvanshi A, Mohindra KD (2010) Cardioembolic stroke on unaffected side during thrombolysis for acute ischemic stroke. Neurol India 58:112–114
Amarenco P, Steg PG (2008) Stroke is a coronary heart disease risk equivalent: implications for future clinical trials in secondary stroke prevention. Eur Heart J 29:1605–1607
Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell PM et al (2005) Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 36:2748–2755
Wysokinski WE, McBane RD 2nd, Owen WG (1999) Individual propensity for arterial thrombosis. Arterioscler Thromb Vasc Biol 19:883–886
Smyth SS, Monroe DM III, Wysokinski WE, McBane RD II, Whiteheart SW et al (2008) Platelet activation and its patient-specific consequences. Thromb Res 122:435–441
Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA et al (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 44:671–719
Tanne D, Macko RF, Lin Y, Tilley BC, Levine SR (2006) Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke 37:1798–1804
Gulba DC, Barthels M, Westhoff-Bleck M, Jost S, Rafflenbeul W et al (1991) Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy. Circulation 83:937–944
Eisenberg PR, Sobel BE, Jaffe AS (1992) Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activator. J Am Coll Cardiol 19:1065–1069
Simoons M, Krzeminska-Pakula M, Alonso A, Goodman S, Kali A et al (2002) Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI–SK study. Eur Heart J 23:1282–1290
International Stroke Trial Collaborative Group (1997) The international stroke trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349:1569–1581
CAST (Chinese Acute Stroke Trial) Collaborative Group (1997) CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 349:1641–1649
Sandercock PA, Gibson LM, Liu M (2009) Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack. Cochrane Database Syst Rev 2:CD000248
Seet RC, Zhang Y, Moore SA, Wijdicks EF, Rabinstein AA (2011) Subtherapeutic international normalized ratio in warfarin-treated patients increases the risk for symptomatic intracerebral hemorrhage after intravenous thrombolysis. Stroke 42:2333–2335
Acknowledgments
The authors wish to thank Susan Quick for outstanding editorial support. This work was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 1UL1RR033173. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was also supported by resources and/or the use of facilities at the Lexington VA Medical Center.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wallace, E.L., Smyth, S.S. Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study. J Thromb Thrombolysis 34, 548–551 (2012). https://doi.org/10.1007/s11239-012-0754-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-012-0754-2